Gabapentin Solution
Product Images NDC 17856-0600

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 17856-0600). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atlantic Biologicals Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

17856 0600 01 Label (2)

17856 0600 01 Label (2)
This is a description for Gabapentin, an oral solution with a dosage of 250mg/5mL. The product code is 17856-0600-01 and it is advised to keep it refrigerated. The label warns to keep this and all drugs out of the reach of children. The GTIN code is 0011786060017 and the SN code is 01302101 RX. The expiration date is 0021. To reorder the product, contact 800.509.7592.*
FDA Label Image

17856 0600 02 Label (2)

17856 0600 02 Label (2)
This is a label for Gabapentin Oral Solution, which contains 300mg/6ml of the medication and requires refrigeration. The label provides information on dosage and storage instructions. It includes a lot number, manufacturing date, and contact information for reordering.*
FDA Label Image

17856 0600 03

17856 0600 03
This text is a description of a medication called Gabapentin Oral Solution. It is a packaged solution with a quantity of 120 syringes, each containing 100mg/2ml of solution. The solution delivers 2ml. The package comes with indications and dosage schedules. It is stored refrigerated at 2°-6°C (36° 46°F) and must be kept out of reach of children. The package was made by Qosa Solutions and distributed by Aant
FDA Label Image

Image Description (Figure 01)

Image Description (Figure 01)
This text provides a formula to calculate the creatinine clearance rate (CLCr) based on the patient's age and weight. The CLCr is determined by multiplying the result of subtracting the patient's age from 140 by their weight in kilograms, and then multiplying that result by their serum creatinine level (in mg/dL) multiplied by 0.85 for female patients.*
FDA Label Image

Image Description (Figure 02)

Image Description (Figure 02)
FDA Label Image

Figure 1 (Figure 03)

Figure 1 (Figure 03)
FDA Label Image

Figure 2 (Figure 04)

Figure 2 (Figure 04)
FDA Label Image

Figure 3 (Figure 05)

Figure 3 (Figure 05)
FDA Label Image

Figure 4 (Figure 06)

Figure 4 (Figure 06)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.